Eisler Capital (UK)’s DexCom DXCM Stock Holding History

Eisler Capital (UK)’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.29M	Buy	+19,200	New	+$1.58M	0.01%	471

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Eisler Capital (UK)'s DXCM Position: Q1 2024 in Review

Eisler Capital (UK) sold out of DexCom (DXCM) in Q1 2024, closing a stake of 10,901 shares — an estimated $1.35M sold.

Eisler Capital (UK) first reported a position in DXCM in Q4 2023 and held it in 1 quarter. The position peaked at $1.35M in Q4 2023. 1,033 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

Eisler Capital (UK) reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
Eisler Capital (UK) sold 10,901 DexCom shares in Q1 2024, an estimated $1.35M.
Eisler Capital (UK) first reported a position in DexCom in Q4 2023 and held it in 1 quarter.
Eisler Capital (UK)'s DexCom position peaked at $1.35M in Q4 2023.
1,033 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Eisler Capital (UK)'s 13F filing for Q1 2024, filed 14 May 2024.